South Africa’s health minister said on Wednesday that most of the Johnson & Johnson Covid-19 vaccine supply for South Africa and the rest of Africa could come from local pharmaceutical company Aspen. Minister Zweli Mkhize added at a virtual briefing to parliament that South Africa was discussing possible joint research work on Russia’s Sputnik V vaccine and that China’s Sinopharm had applied to regulator SAHPRA for registration of its vaccine. Subscribe for full access to all our share and unit trust data tools, our award-winning articles, and support quality journalism in the process. You will be redirected to a checkout page.
To view all features and options, click here. A monthly subscription is charged pro rata, based on the day of purchase. This is non-refundable and includes a R5 once-off sign-up fee.
A yearly subscription is refundable within 14 days of purchase and includes a 365-day membership.